1,401,923 filings since 2004 · latest accepted Nov 3, 2026, 5:27 PM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
Aug 5, 2026 accepted 4:04 PM ET | VTGNVistagen Therapeutics, Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Apr 2, 2026 accepted 4:16 PM ET | VTGNVistagen Therapeutics, Inc. | 3.01Delisting notice |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
Feb 6, 2026 accepted 4:12 PM ET | VTGNVistagen Therapeutics, Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Mar 7, 2023 accepted 4:40 PM ET | VTGNVistagen Therapeutics, Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Sep 7, 2022 accepted 4:05 PM ET | VTGNVistagen Therapeutics, Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Oct 13, 2020 accepted 5:06 PM ET | VTGNVistagen Therapeutics, Inc. | 3.01Delisting notice7.01Reg FD disclosure | DocumentSEC ↗ |
Apr 3, 2020 accepted 5:15 PM ET | VTGNVistagen Therapeutics, Inc. | 3.01Delisting notice8.01Other events | DocumentSEC ↗ |
Jan 31, 2020 accepted 5:22 PM ET | VTGNVistagen Therapeutics, Inc. | 3.01Delisting notice8.01Other events | DocumentSEC ↗ |
Aug 23, 2019 accepted 4:37 PM ET | VTGNVistagen Therapeutics, Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Jun 21, 2019 accepted 5:00 PM ET | VTGNVistagen Therapeutics, Inc. | 3.01Delisting notice8.01Other events | DocumentSEC ↗ |